Exercise Intervention and Immunodeficiency

Part of paid clinical trials in Milford, Connecticut.

Sponsor
Yale University
Study ID
NCT07698197
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Primary Antibody Deficiency Disorders

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • App-based exercise intervention — BEHAVIORAL
    12 week structured moderate-intensity exercise intervention delivered via a mobile application

Study Details

The purpose of this study is to assess if a 12-week exercise program is safe, practical, and acceptable for adults with primary antibody deficiencies. It also looks at whether the program can improve the quality of life and help the immune system work better.

Key Dates

First listed
Jul 13, 2026
Start date
Jul 31, 2026
Status verified
Jul 2026
Primary completion
Jul 31, 2027
Completion
Jul 31, 2027

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: App-based exercise intervention
    12-week, app-based exercise intervention in adults with primary antibody deficiencies with completion of survey procedures and collection of clinical and laboratory data

Primary Outcome Measure

Recruitment rate [ Time Frame: Day 1 ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Bridgeport HospitalMilfordConnecticut06460-
Yale New Haven HealthNorth HavenConnecticut06473-

Find similar trials in Milford, CT